US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.300
  • -0.250-5.49%
Close Apr 24 15:59 ET
  • 4.300
  • 0.0000.00%
Post 20:01 ET
600.55MMarket Cap-8.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-20.11%90.75M
-20.11%90.75M
-24.91%95.91M
-10.16%99.81M
-17.83%105.31M
-4.63%113.59M
-4.63%113.59M
23.94%127.72M
-7.25%111.09M
-24.96%128.17M
-Cash and cash equivalents
-18.76%19.96M
-18.76%19.96M
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-38.39%24.57M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
-Short-term investments
-20.48%70.79M
-20.48%70.79M
-11.76%70.66M
-15.70%74.4M
-18.81%74.96M
12.36%89.02M
12.36%89.02M
25.09%80.07M
-0.41%88.26M
-26.77%92.33M
Receivables
----
----
1,264.43%4.68M
-40.31%194K
-32.98%250K
6.71%318K
6.71%318K
-0.87%343K
-24.59%325K
-45.63%373K
-Accounts receivable
----
----
1,264.43%4.68M
-40.31%194K
-32.98%250K
6.71%318K
6.71%318K
-0.87%343K
-24.59%325K
-45.63%373K
Other current assets
-54.96%5.57M
-54.96%5.57M
----
-32.41%4.2M
-52.55%3.23M
30.73%12.36M
30.73%12.36M
-78.32%4.27M
-51.16%6.22M
-47.18%6.8M
Total current assets
-23.53%96.32M
-23.53%96.32M
-23.98%100.59M
-11.42%104.2M
-19.62%108.79M
-2.25%125.95M
-2.25%125.95M
7.53%132.33M
-11.51%117.64M
-26.59%135.34M
Non current assets
Net PPE
-24.50%761K
-24.50%761K
-28.42%811K
-32.87%868K
-38.47%942K
-37.78%1.01M
-37.78%1.01M
-35.77%1.13M
-31.91%1.29M
1.19%1.53M
-Gross PPE
----
----
-0.31%5.8M
1.12%5.88M
-0.24%5.86M
0.54%5.81M
0.54%5.81M
-8.72%5.81M
-7.85%5.81M
2.55%5.87M
-Accumulated depreciation
----
----
-6.50%-4.98M
-10.84%-5.01M
-13.25%-4.91M
-15.45%-4.81M
-15.45%-4.81M
-1.65%-4.68M
-2.52%-4.52M
-3.04%-4.34M
Investments and advances
-32.88%60.61M
-32.88%60.61M
55.96%71.3M
109.10%81.08M
156.67%85.21M
43.86%90.3M
43.86%90.3M
-45.54%45.71M
-57.38%38.78M
-1.20%33.2M
Other non current assets
-9.62%2.77M
-9.62%2.77M
-11.91%2.83M
-11.05%2.99M
-21.17%3.15M
-26.26%3.07M
-26.26%3.07M
20.89%3.22M
16.52%3.37M
22.05%4M
Total non current assets
-32.03%64.14M
-32.03%64.14M
49.69%74.94M
95.56%84.95M
130.60%89.3M
37.68%94.38M
37.68%94.38M
-47.46%50.06M
-57.71%43.44M
-14.59%38.73M
Total assets
-27.17%160.46M
-27.17%160.46M
-3.76%175.53M
17.43%189.15M
13.80%198.09M
11.61%220.33M
11.61%220.33M
-16.47%182.39M
-31.65%161.07M
-24.22%174.07M
Liabilities
Current liabilities
Payables
180.55%13.16M
180.55%13.16M
19.90%9.19M
21.02%8.8M
-41.22%6.35M
-47.17%4.69M
-47.17%4.69M
-20.58%7.66M
-36.38%7.27M
31.99%10.81M
-accounts payable
180.55%13.16M
180.55%13.16M
19.90%9.19M
21.02%8.8M
-41.22%6.35M
-47.17%4.69M
-47.17%4.69M
-20.58%7.66M
-36.38%7.27M
31.99%10.81M
Current accrued expenses
-69.43%3.49M
-69.43%3.49M
72.53%3.66M
-10.18%3.26M
-23.12%3.75M
-26.45%11.43M
-26.45%11.43M
-79.21%2.12M
-25.11%3.62M
5.23%4.87M
Current deferred liabilities
-49.56%3.94M
-49.56%3.94M
67.25%6.3M
--9.33M
--6.98M
--7.82M
--7.82M
--3.77M
----
----
Other current liabilities
2.61%2.75M
2.61%2.75M
2.55%2.74M
2.49%2.72M
-0.18%2.7M
2.09%2.68M
2.09%2.68M
21.12%2.67M
20.39%2.65M
22.84%2.71M
Current liabilities
-9.34%28.65M
-9.34%28.65M
36.22%25.63M
71.15%26.84M
7.14%21.51M
2.08%31.6M
2.08%31.6M
-31.13%18.82M
-31.31%15.68M
9.98%20.08M
Non current liabilities
Non current deferred liabilities
-19.31%16.17M
-19.31%16.17M
-17.42%17.49M
--18.22M
--19.21M
--20.04M
--20.04M
5,671.66%21.18M
----
----
Other non current liabilities
-4.37%12.57M
-4.37%12.57M
0.54%12.31M
6.78%12.35M
11.17%13.31M
41.68%13.14M
41.68%13.14M
-64.34%12.25M
-64.63%11.57M
-65.07%11.97M
Total non current liabilities
-13.39%28.73M
-13.39%28.73M
-10.84%29.8M
164.28%30.57M
171.61%32.51M
257.74%33.18M
257.74%33.18M
-3.67%33.43M
-65.02%11.57M
-65.44%11.97M
Total liabilities
-11.42%57.38M
-11.42%57.38M
6.11%55.43M
110.68%57.41M
68.57%54.03M
61.02%64.77M
61.02%64.77M
-15.77%52.24M
-51.25%27.25M
-39.41%32.05M
Shareholders'equity
Share capital
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
-common stock
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-7.19%-967.78M
-7.19%-967.78M
-17.57%-947.99M
-16.86%-933.38M
-16.53%-917.95M
-17.13%-902.86M
-17.13%-902.86M
-4.81%-806.31M
-7.93%-798.72M
-10.87%-787.74M
Paid-in capital
1.13%1.07B
1.13%1.07B
14.04%1.07B
14.11%1.06B
14.13%1.06B
14.03%1.06B
14.03%1.06B
1.00%936.03M
1.31%933.01M
4.79%930.11M
Gains losses not affecting retained earnings
528.87%610K
528.87%610K
39.81%597K
204.10%482K
219.23%434K
191.51%97K
191.51%97K
137.82%427K
58.33%-463K
-2.82%-364K
Total stockholders'equity
-33.73%103.08M
-33.73%103.08M
-7.72%120.1M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
-19.68%142.01M
Total equity
-33.73%103.08M
-33.73%103.08M
-7.72%120.1M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
-19.68%142.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -20.11%90.75M-20.11%90.75M-24.91%95.91M-10.16%99.81M-17.83%105.31M-4.63%113.59M-4.63%113.59M23.94%127.72M-7.25%111.09M-24.96%128.17M
-Cash and cash equivalents -18.76%19.96M-18.76%19.96M-47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-38.39%24.57M22.06%47.65M-26.70%22.83M-19.86%35.84M
-Short-term investments -20.48%70.79M-20.48%70.79M-11.76%70.66M-15.70%74.4M-18.81%74.96M12.36%89.02M12.36%89.02M25.09%80.07M-0.41%88.26M-26.77%92.33M
Receivables --------1,264.43%4.68M-40.31%194K-32.98%250K6.71%318K6.71%318K-0.87%343K-24.59%325K-45.63%373K
-Accounts receivable --------1,264.43%4.68M-40.31%194K-32.98%250K6.71%318K6.71%318K-0.87%343K-24.59%325K-45.63%373K
Other current assets -54.96%5.57M-54.96%5.57M-----32.41%4.2M-52.55%3.23M30.73%12.36M30.73%12.36M-78.32%4.27M-51.16%6.22M-47.18%6.8M
Total current assets -23.53%96.32M-23.53%96.32M-23.98%100.59M-11.42%104.2M-19.62%108.79M-2.25%125.95M-2.25%125.95M7.53%132.33M-11.51%117.64M-26.59%135.34M
Non current assets
Net PPE -24.50%761K-24.50%761K-28.42%811K-32.87%868K-38.47%942K-37.78%1.01M-37.78%1.01M-35.77%1.13M-31.91%1.29M1.19%1.53M
-Gross PPE ---------0.31%5.8M1.12%5.88M-0.24%5.86M0.54%5.81M0.54%5.81M-8.72%5.81M-7.85%5.81M2.55%5.87M
-Accumulated depreciation ---------6.50%-4.98M-10.84%-5.01M-13.25%-4.91M-15.45%-4.81M-15.45%-4.81M-1.65%-4.68M-2.52%-4.52M-3.04%-4.34M
Investments and advances -32.88%60.61M-32.88%60.61M55.96%71.3M109.10%81.08M156.67%85.21M43.86%90.3M43.86%90.3M-45.54%45.71M-57.38%38.78M-1.20%33.2M
Other non current assets -9.62%2.77M-9.62%2.77M-11.91%2.83M-11.05%2.99M-21.17%3.15M-26.26%3.07M-26.26%3.07M20.89%3.22M16.52%3.37M22.05%4M
Total non current assets -32.03%64.14M-32.03%64.14M49.69%74.94M95.56%84.95M130.60%89.3M37.68%94.38M37.68%94.38M-47.46%50.06M-57.71%43.44M-14.59%38.73M
Total assets -27.17%160.46M-27.17%160.46M-3.76%175.53M17.43%189.15M13.80%198.09M11.61%220.33M11.61%220.33M-16.47%182.39M-31.65%161.07M-24.22%174.07M
Liabilities
Current liabilities
Payables 180.55%13.16M180.55%13.16M19.90%9.19M21.02%8.8M-41.22%6.35M-47.17%4.69M-47.17%4.69M-20.58%7.66M-36.38%7.27M31.99%10.81M
-accounts payable 180.55%13.16M180.55%13.16M19.90%9.19M21.02%8.8M-41.22%6.35M-47.17%4.69M-47.17%4.69M-20.58%7.66M-36.38%7.27M31.99%10.81M
Current accrued expenses -69.43%3.49M-69.43%3.49M72.53%3.66M-10.18%3.26M-23.12%3.75M-26.45%11.43M-26.45%11.43M-79.21%2.12M-25.11%3.62M5.23%4.87M
Current deferred liabilities -49.56%3.94M-49.56%3.94M67.25%6.3M--9.33M--6.98M--7.82M--7.82M--3.77M--------
Other current liabilities 2.61%2.75M2.61%2.75M2.55%2.74M2.49%2.72M-0.18%2.7M2.09%2.68M2.09%2.68M21.12%2.67M20.39%2.65M22.84%2.71M
Current liabilities -9.34%28.65M-9.34%28.65M36.22%25.63M71.15%26.84M7.14%21.51M2.08%31.6M2.08%31.6M-31.13%18.82M-31.31%15.68M9.98%20.08M
Non current liabilities
Non current deferred liabilities -19.31%16.17M-19.31%16.17M-17.42%17.49M--18.22M--19.21M--20.04M--20.04M5,671.66%21.18M--------
Other non current liabilities -4.37%12.57M-4.37%12.57M0.54%12.31M6.78%12.35M11.17%13.31M41.68%13.14M41.68%13.14M-64.34%12.25M-64.63%11.57M-65.07%11.97M
Total non current liabilities -13.39%28.73M-13.39%28.73M-10.84%29.8M164.28%30.57M171.61%32.51M257.74%33.18M257.74%33.18M-3.67%33.43M-65.02%11.57M-65.44%11.97M
Total liabilities -11.42%57.38M-11.42%57.38M6.11%55.43M110.68%57.41M68.57%54.03M61.02%64.77M61.02%64.77M-15.77%52.24M-51.25%27.25M-39.41%32.05M
Shareholders'equity
Share capital 0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K
-common stock 0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -7.19%-967.78M-7.19%-967.78M-17.57%-947.99M-16.86%-933.38M-16.53%-917.95M-17.13%-902.86M-17.13%-902.86M-4.81%-806.31M-7.93%-798.72M-10.87%-787.74M
Paid-in capital 1.13%1.07B1.13%1.07B14.04%1.07B14.11%1.06B14.13%1.06B14.03%1.06B14.03%1.06B1.00%936.03M1.31%933.01M4.79%930.11M
Gains losses not affecting retained earnings 528.87%610K528.87%610K39.81%597K204.10%482K219.23%434K191.51%97K191.51%97K137.82%427K58.33%-463K-2.82%-364K
Total stockholders'equity -33.73%103.08M-33.73%103.08M-7.72%120.1M-1.56%131.74M1.44%144.07M-1.03%155.55M-1.03%155.55M-16.75%130.15M-25.55%133.82M-19.68%142.01M
Total equity -33.73%103.08M-33.73%103.08M-7.72%120.1M-1.56%131.74M1.44%144.07M-1.03%155.55M-1.03%155.55M-16.75%130.15M-25.55%133.82M-19.68%142.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -